Skip to main content

Published locations for Amyloid β-Lowering Agent Fails in Phase III : Patients who received 800 mg of the drug saw the same cognitive decline as patients taking placebo.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Amyloid β-Lowering Agent Fails in Phase III : Patients who received 800 mg of the drug saw the same cognitive decline as patients taking placebo.

User login

  • Reset your password
  • /content/amyloid-v-lowering-agent-fails-phase-iii-patients-who-received-800-mg-drug-saw-same
  • /neurology/article/48084/alzheimers-cognition/amyloid-v-lowering-agent-fails-phase-iii-patients-who
  • /clinicalneurologynews/article/48084/alzheimers-cognition/amyloid-v-lowering-agent-fails-phase-iii